Lunai Bioworks (LNAI) Goodwill & Intangibles (2012 - 2026)
Lunai Bioworks (LNAI) posted quarterly Goodwill & Intangibles of $119115.0 for Q1 2026, up 636.55% year-over-year from $16172.0 in Q1 2025, and down 16.17% quarter-over-quarter from $142096.0 in Q4 2025.
Lunai Bioworks (LNAI) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
Lunai Bioworks' Goodwill & Intangibles history runs 15 years deep, the most recent figure standing at $119115.0 for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 636.55% year-over-year to $119115.0; the TTM figure through Mar 2026 stood at $119115.0 (up 636.55% YoY), while the FY2025 annual figure was $165994.0, up 452.52% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $119115.0, down from $142096.0 in the prior quarter.
- The five-year high for Goodwill & Intangibles was $174.9 million in Q1 2024, with the low at $16172.0 in Q1 2025.
- The 5-year median for Goodwill & Intangibles is $152980.0 (2025), against an average of $24.2 million.
- The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles soared 1397.65% in 2024, then sank 99.99% in 2025.
- Lunai Bioworks' Goodwill & Intangibles stood at $73.2 million in 2022, then tumbled by 84.06% to $11.7 million in 2023, then slumped by 99.85% to $17853.0 in 2024, then jumped by 695.92% to $142096.0 in 2025, then retreated by 16.17% to $119115.0 in 2026.
- Business Quant data shows LNAI's Goodwill & Intangibles at $119115.0 in Q1 2026, $142096.0 in Q4 2025, and $152980.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,115.00 |
| Dec 31, 2025 | 142,096.00 |
| Sep 30, 2025 | 152,980.00 |
| Jun 30, 2025 | 165,994.00 |
| Mar 31, 2025 | 16,172.00 |
| Dec 31, 2024 | 17,853.00 |
| Sep 30, 2024 | 28,750.00 |
| Jun 30, 2024 | 30,043.00 |
| Mar 31, 2024 | 174.94 Mn |
| Dec 31, 2023 | 11.67 Mn |
| Sep 30, 2023 | 54.25 Mn |
| Jun 30, 2023 | 39,676.00 |
| Mar 31, 2023 | 11.68 Mn |
| Dec 31, 2022 | 73.21 Mn |
| Sep 30, 2022 | 73.21 Mn |
| Jun 30, 2022 | 44,268.00 |
| Mar 31, 2022 | 11.69 Mn |
| Dec 31, 2021 | 178.10 Mn |
| Sep 30, 2021 | 178.10 Mn |
| Jun 30, 2021 | 11.71 Mn |